IP Library › Assignment 072302/0591
Patent Assignment
Reel/Frame 072302/0591

Assignment of Assignor's Interest

Recorded: 2025-09-18 Pages: 7
Assignor
Assignee
BIONTECH SE
AN DER GOLDGRUBE 12, MAINZ, 55131, GERMANY
Covered Properties (6)
Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A
Patent: 9,475,874 →
Application: 14/468,827 →
Publication: US 2015/0056134
Nucleic Acids Encoding Human Antibodies to Sialyl-Lewis A
Application: 15/275,174 →
Publication: US 2017/0015756
Nucleic Acids Encoding Human Antibodies to Sialyl-Lewis A
Application: 16/788,251 →
Publication: US 2020/0247900
Human Monoclonal Antibodies to Ganglioside GD2
Patent: 9,856,324 →
Application: 14/730,036 →
Publication: US 2015/0353645
Human Monoclonal Antibodies to Ganglioside GD2
Application: 15/839,391 →
Publication: US 2018/0346597
Human Monoclonal Antibodies to Ganglioside GD2
Application: 18/363,136 →
Publication: US 2024/0124609
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2014
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 034168/0480 →
Assignment of Assignor's Interest Aug 10, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 036291/0269 →
Assignment of Assignor's Interest Dec 15, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 037296/0710 →
Security Interest Jul 12, 2018
From: MABVAX THERAPEUTICS HOLDINGS, INC.; MABVAX THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS A LENDER
Reel/Frame 046337/0252 →
Assignment of Assignor's Interest Jun 21, 2019
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 049556/0114 →
Assignment of Assignor's Interest Jun 21, 2019
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 049556/0001 →
Assignment of Assignor's Interest Jun 26, 2019
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 049586/0362 →
Change of Address in Recorded Assignment Jan 31, 2020
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 051762/0305 →
Assignment of Assignor's Interest Feb 28, 2020
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 051967/0554 →
Assignment of Assignor's Interest Feb 28, 2020
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 051967/0585 →
Assignment of Assignor's Interest Sep 18, 2025
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 072302/0637 →
Assignment of Assignor's Interest Sep 18, 2025
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 072302/0640 →